TAM receptors in apoptotic cell clearance, autoimmunity, and cancer

References

• Savill J., Fadok V.. Corpse clearance defines the meaning of cell death. Nature. 2000; 407:784.
   PubMed Web of Science ®Google Scholar
• Fadok V. A., Bratton D. L., Konowal A., . Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. J. Clin. Invest. 1998; 101:890.
   PubMed Web of Science ®Google Scholar
• Thorp E., Cui D., Schrijvers D. M., Kuriakos G., Tabas I.. Mertk receptor mutation reduces efferocytosis efficiency and promotes apoptotic cell accumulation and plaque necrosis in atherosclerotic lesions of apoe-/- mice. Arterioscler. Thromb. Vasc. Biol. 2008; 28:1421.
   Google Scholar
• Wallet M. A., Sen P., Flores R. R., . MerTK is required for apoptotic cell-induced T cell tolerance. J. Exp. Med. 2008; 205:219.
   PubMed Web of Science ®Google Scholar
• Scott R. S., McMahon E. J., Pop S. M., . Phagocytosis and clearance of apoptotic cells is mediated by MER. Nature. 2001; 411:207.
   PubMed Web of Science ®Google Scholar
• Botto M., Dell'Agnola C., Bygrave A. E., . Homozygous C1q deficiency causes glomerulonephritis associated with multiple apoptotic bodies. Nat. Genet. 1998; 19:56.
   PubMed Web of Science ®Google Scholar
• Gaipl U. S., Kuhn A., Sheriff A., . Clearance of apoptotic cells in human SLE. Curr. Dir. Autoimmun. 2006; 9:173.
   PubMedGoogle Scholar
• Elliott M. R., Ravichandran K. S.. Clearance of apoptotic cells: implications in health and disease. J. Cell. Biol. 2010; 189:1059.
   PubMed Web of Science ®Google Scholar
• Linger R. M., Keating A. K., Earp H. S., Graham D. K.. TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer. Adv. Cancer Res. 2008; 100:35.
   PubMed Web of Science ®Google Scholar
• Cohen P. L., Caricchio R., Abraham V., . Delayed apoptotic cell clearance and lupus-like autoimmunity in mice lacking the c-mer membrane tyrosine kinase. J. Exp. Med. 2002; 196:135.
   PubMed Web of Science ®Google Scholar
• Lu Q., Lemke G.. Homeostatic regulation of the immune system by receptor tyrosine kinases of the Tyro 3 family. Science. 2001; 293:306.
   PubMed Web of Science ®Google Scholar
• Camenisch T. D., Koller B. H., Earp H. S., Matsushima G. K.. A novel receptor tyrosine kinase, Mer, inhibits TNF-alpha production and lipopolysaccharide-induced endotoxic shock. J. Immunol. 1999; 162:3498.
   PubMed Web of Science ®Google Scholar
• Sen P., Wallet M. A., Yi Z., . Apoptotic cells induce Mer tyrosine kinase-dependent blockade of NF-kappaB activation in dendritic cells. Blood. 2007; 109:653.
   PubMed Web of Science ®Google Scholar
• Gohlke P. R., Williams J. C., Vilen B. J.. The receptor tyrosine kinase MerTK regulates dendritic cell production of BAFF. Autoimmunity. 2009; 42:183.
   PubMed Web of Science ®Google Scholar
• Baumann I., Kolowos W., Voll R. E., . Impaired uptake of apoptotic cells into tingible body macrophages in germinal centers of patients with systemic lupus erythematosus. Arthritis Rheum. 2002; 46:191.
   PubMed Web of Science ®Google Scholar
• Shao W. H., Zhen Y., Eisenberg R. A., Cohen P. L.. The Mer receptor tyrosine kinase is expressed on discrete macrophage subpopulations and mainly uses Gas6 as its ligand for uptake of apoptotic cells. Clin. Immunol. 2009; 133:138.
   PubMed Web of Science ®Google Scholar
• Shao W. H., Kuan A. P., Wang C., . Disrupted Mer receptor tyrosine kinase expression leads to enhanced MZ B-cell responses. J. Autoimmun. 2010; 35:368.
   PubMed Web of Science ®Google Scholar
• Rahman Z. S., Shao W. H., Khan T. N., Zhen Y., Cohen P. L.. Impaired apoptotic cell clearance in the germinal center by Mer-deficient tingible body macrophages leads to enhanced antibody-forming cell and germinal center responses. J. Immunol. 2010; 185:5859.
   PubMed Web of Science ®Google Scholar
• Cheong H. S., Lee S. O., Choi C. B.. MERTK polymorphisms associated with risk of haematological disorders among Korean SLE patients. Rheumatology (Oxford). 2007; 46:209.
   PubMed Web of Science ®Google Scholar
• Wu J., Ekman C., Jonsen A., . Increased plasma levels of the soluble Mer tyrosine kinase receptor in systemic lupus erythematosus relate to disease activity and nephritis. Arthritis Res. Ther. 2011; 13:R62.
   PubMed Web of Science ®Google Scholar
• Suh C. H., Hilliard B., Li S., Merrill J. T., Cohen P. L.. TAM receptor ligands in lupus: protein S but not Gas6 levels reflect disease activity in systemic lupus erythematosus. Arthritis Res. Ther. 2010; 12:R146.
   PubMed Web of Science ®Google Scholar
• Caberoy N. B., Zhou Y., Li W.. Tubby and tubby-like protein 1 are new MerTK ligands for phagocytosis. EMBO J. 2010; 29:3898.
   PubMed Web of Science ®Google Scholar
• Caberoy N. B., Alvarado G., Bigcas J. L., Li W.. Galectin-3 is a new MerTK-specific eat-me signal. J. Cell. Physiol. 2012; 227:401.
   PubMed Web of Science ®Google Scholar
• Wong C. C., Lee W. M.. The proximal cis-acting elements Sp1, Sp3 and E2F regulate mouse mer gene transcription in Sertoli cells. Eur. J. Biochem. 2002; 269:3789.
   PubMedGoogle Scholar
• Mudduluru G., Leupold J. H., Stroebel P., Allgayer H.. PMA up-regulates the transcription of Axl by AP-1 transcription factor binding to TRE sequences via the MAPK cascade in leukaemia cells. Biol. Cell. 2010; 103:21.
   PubMed Web of Science ®Google Scholar
• McColl A., Bournazos S., Franz S., . Glucocorticoids induce protein S-dependent phagocytosis of apoptotic neutrophils by human macrophages. J. Immunol. 2009; 183:2167.
   PubMed Web of Science ®Google Scholar
• Zahuczky G., Kristof E., Majai G., Fesus L.. Differentiation and glucocorticoid regulated apopto-phagocytic gene expression patterns in human macrophages. Role of Mertk in enhanced phagocytosis. PLoS One. 2011; 6:e21349.
   Web of Science ®Google Scholar
• Galvan M. D., Foreman D. B., Zeng E., Tan J. C., Bohlson S. S.. Complement component C1q regulates macrophage expression of Mer tyrosine kinase to promote clearance of apoptotic cells. J. Immunol. 2012; 188:3716.
   PubMed Web of Science ®Google Scholar
• Budagian V., Bulanova E., Orinska Z., . Soluble Axl is generated by ADAM10-dependent cleavage and associates with Gas6 in mouse serum. Mol. Cell Biol. 2005; 25:9324.
   PubMed Web of Science ®Google Scholar
• Seitz H. M., Camenisch T. D., Lemke G., Earp H. S., Matsushima G. K.. Macrophages and dendritic cells use different Axl/Mertk/Tyro3 receptors in clearance of apoptotic cells. J. Immunol. 2007; 178:5635.
   PubMed Web of Science ®Google Scholar
• Nandrot E. F., Silva K. E., Scelfo C., Finnemann S. C.. Retinal pigment epithelial cells use a MerTK-dependent mechanism to limit the phagocytic particle binding activity of alphavbeta5 integrin. Biol. Cell. 2012; 104:326.
   PubMed Web of Science ®Google Scholar
• Sandahl M., Hunter D. M., Strunk K. E., Earp H. S., Cook R. S.. Epithelial cell-directed efferocytosis in the post-partum mammary gland is necessary for tissue homeostasis and future lactation. BMC Dev. Biol. 2010; 10:122.
   Google Scholar
• Rothlin C. V., Ghosh S., Zuniga E. I., Oldstone M. B., Lemke G.. TAM receptors are pleiotropic inhibitors of the innate immune response. Cell. 2007; 131:1124.
   PubMed Web of Science ®Google Scholar
• Sharif M. N., Sosic D., Rothlin C. V., . Twist mediates suppression of inflammation by type I IFNs and Axl. J. Exp. Med. 2006; 203:1891.
   PubMed Web of Science ®Google Scholar
• Rothlin C. V., Lemke G.. TAM receptor signaling and autoimmune disease. Curr. Opin. Immunol. 2010; 22:740.
   PubMed Web of Science ®Google Scholar
• Png K. J., Halber N., Yoshida M., Tavazoie S. F.. A microRNA regulon that mediates endothelial recruitment and metastasis by cancer cells. Nature. 2011; 481:190.
   PubMed Web of Science ®Google Scholar
• Mudduluru G., Ceppi P., Kumarswamy R.. Regulation of Axl receptor tyrosine kinase expression by miR-34a and miR-199a/b in solid cancer. Oncogene. 2011; 30:2888.
   PubMed Web of Science ®Google Scholar
• Apetoh L., Ghiringhelli F., Tesniere A., . Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nat. Med. 2007; 13:1050.
   PubMed Web of Science ®Google Scholar
• Holland S. J., Pan A., Franci C., . R428, a selective small molecule inhibitor of Axl kinase, blocks tumor spread and prolongs survival in models of metastatic breast cancer. Cancer Res. 2010; 70:1544.
   PubMed Web of Science ®Google Scholar
• Bondanza A., Zimmermann V. S., Rovere-Querini P., . Inhibition of phosphatidylserine recognition heightens the immunogenicity of irradiated lymphoma cells in vivo. J. Exp. Med. 2004; 200:1157.
   PubMed Web of Science ®Google Scholar
• He J., Yin Y., Luster T. A., Watkins L., Thorpe P. E.. Antiphosphatidylserine antibody combined with irradiation damages tumor blood vessels and induces tumor immunity in a rat model of glioblastoma. Clin. Cancer Res. 2009; 15:6871.
   PubMed Web of Science ®Google Scholar
• Marconescu A., Thorpe P. E.. Coincident exposure of phosphatidylethanolamine and anionic phospholipids on the surface of irradiated cells. Biochim. Biophys. Acta. 2008; 1778:2217.
   PubMed Web of Science ®Google Scholar